ARIAD Pharmaceuticals, Inc. ARIA remains focused on the discovery, development and commercialization of breakthrough treatments for cancer. This year was a tough one for the pharma sector, which had to grapple …
Strong
Ariad stock rocketed nearly 73% on Jan. 9 when the company announced it had reached an agreement to be acquired, an announcement timed to coincide with the JPMorgan Healthcare Conference in San Francisco, …
Royal Bank of Canada
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock closed up 3.18% Wednesday evening on rumors that the US-based oncology company is being targeted by AstraZeneca plc (ADR) (NYSE:AZN) and Shire plc (ADR) …
Moving forward, I've got incredibly high hopes for Ariad Pharmaceuticals stock. As seen in the data that was provided yesterday, the company continues to innovate and find ways to make the quality of life for those …
This unexpected finding resulted in the FDA pulling the product from the market. Ariad's stock plunged. However, patients and physicians with drug resistant CML, who now no longer had an effective drug, lobbied hard to get …
Seeking Alpha
for each share of ARIAD stock. Following the purchase of shares in the tender offer, ARIAD will become an …
Business Wire
Below is a chart showing the trailing twelve month trading history for ARIAD Pharmaceuticals, Inc., and highlighting in green where the $3.50 strike is located relative to that history: The chart above, and the stock’s …
Ariad Pharmaceuticals (NASDAQ: ARIA) already has one FDA-approved drug on the market, but that doesn't mean it's immune to the risks that face every biotech stock. The company is making significant investments …
Risk
ARIAD Pharmaceuticals Inc.’s (NASDAQ:ARIA) shares were up 12.5% with the company swinging to a profit in the second quarter of 2016. ARIAD reported second quarter 2016 earnings of 57 cents per share, far better …
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) has been given an average rating of “Hold” by the eleven analysts that are currently covering the stock. One analyst has rated the stock with a sell recommendation, eight have …
Australian Recording Industry Association